Document is current

Any future updates will be listed below

562 A phase Ia study to assess the safety, tolerability and immunogenicity of a personalized cancer vaccine (InnoPCV/INV002) in patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0562

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark